Improved Pregnancy Outcomes in Women with Type 1 and Type 2 Diabetes but Substantial Clinic-to-clinic Variations: a Prospective Nationwide Study

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2017 Jun 10

PMID 28597075

Citations 69

Authors

Helen R Murphy

Ruth Bell

Cher Cartwright

Paula Curnow

Michael Maresh

Margery Morgan

Catherine Sylvester

Bob Young

Nick Lewis-Barned

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The aim of this prospective nationwide study was to examine antenatal pregnancy care and pregnancy outcomes in women with type 1 and type 2 diabetes, and to describe changes since 2002/2003.

Methods: This national population-based cohort included 3036 pregnant women with diabetes from 155 maternity clinics in England and Wales who delivered during 2015. The main outcome measures were maternal glycaemic control, preterm delivery (before 37 weeks), infant large for gestational age (LGA), and rates of congenital anomaly, stillbirth and neonatal death.

Results: Of 3036 women, 1563 (51%) had type 1, 1386 (46%) had type 2 and 87 (3%) had other types of diabetes. The percentage of women achieving HbA < 6.5% (48 mmol/mol) in early pregnancy varied greatly between clinics (median [interquartile range] 14.3% [7.7-22.2] for type 1, 37.0% [27.3-46.2] for type 2). The number of infants born preterm (21.7% vs 39.7%) and LGA (23.9% vs 46.4%) were lower for women with type 2 compared with type 1 diabetes (both p < 0.001). The prevalence rates for congenital anomaly (46.2/1000 births for type 1, 34.6/1000 births for type 2) and neonatal death (8.1/1000 births for type 1, 11.4/1000 births for type 2) were unchanged since 2002/2003. Stillbirth rates are almost 2.5 times lower than in 2002/2003 (10.7 vs 25.8/1000 births for type 1, p = 0.0012; 10.5 vs 29.2/1000 births for type 2, p = 0.0091).

Conclusions/interpretation: Stillbirth rates among women with type 1 and type 2 diabetes have decreased since 2002/2003. Rates of preterm delivery and LGA infants are lower in women with type 2 compared with type 1 diabetes. In women with type 1 diabetes, suboptimal glucose control and high rates of perinatal morbidity persist with substantial variations between clinics.

Data Availability: Further details of the data collection methodology, individual clinic data and the full audit reports for healthcare professionals and service users are available from http://content.digital.nhs.uk/npid .

Citing Articles

Beyond individual-level factors that influence family planning uptake among women with diabetes mellitus: a systematic literature review.

Idris I, Dahlan S, Rahman R, Mohammed Nawi A BMC Public Health. 2025; 25(1):317.

PMID: 39856579 PMC: 11762064. DOI: 10.1186/s12889-024-20784-3.

Impact of continuous glucose monitoring on pregnancy outcomes in women with pregestational diabetes.

Hinojal I, Chimenea A, Antinolo G, Garcia-Diaz L Acta Diabetol. 2025; .

PMID: 39760786 DOI: 10.1007/s00592-024-02439-2.

Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study.

Perea V, Quiros C, Herrera-Arranz M, Azriel-Mira S, Wagner A, Beato-Vibora P Acta Diabetol. 2024; .

PMID: 39630235 DOI: 10.1007/s00592-024-02430-x.

A systematic literature review on how consumer and community involvement have shaped and influenced pre-pregnancy care interventions for women with diabetes.

Hicks R, Dune T, Gu V, Simmons D, MacMillan F BMC Pregnancy Childbirth. 2024; 24(1):748.

PMID: 39538160 PMC: 11562801. DOI: 10.1186/s12884-024-06951-9.

Causal pathways in preeclampsia: a Mendelian randomization study in European populations.

Tan Z, Ding M, Shen J, Huang Y, Li J, Sun A Front Endocrinol (Lausanne). 2024; 15:1453277.

PMID: 39286274 PMC: 11402816. DOI: 10.3389/fendo.2024.1453277.

References

Chaiworapongsa T, Romero R, Korzeniewski S, Kusanovic J, Soto E, Lam J . Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol. 2013; 208(4):287.e1-287.e15. PMC: 4086897. DOI: 10.1016/j.ajog.2013.01.016. View

Teramo K, Kari M, Eronen M, Markkanen H, Hiilesmaa V . High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia. 2004; 47(10):1695-703. DOI: 10.1007/s00125-004-1515-3. View

Klemetti M, Nuutila M, Tikkanen M, Kari M, Hiilesmaa V, Teramo K . Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008. Diabetologia. 2012; 55(9):2327-34. DOI: 10.1007/s00125-012-2627-9. View

Evers I, de Valk H, Mol B, Ter Braak E, Visser G . Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia. 2002; 45(11):1484-9. DOI: 10.1007/s00125-002-0958-7. View

. Association between stillbirth and risk factors known at pregnancy confirmation. JAMA. 2011; 306(22):2469-79. PMC: 3807602. DOI: 10.1001/jama.2011.1798. View

Familiari A, Scala C, Morlando M, Bhide A, Khalil A, Thilaganathan B . Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth. Acta Obstet Gynecol Scand. 2016; 95(11):1313-1318. DOI: 10.1111/aogs.13012. View

Murphy H, Bell R, Holt R, Maresh M, Todd D, Hawdon J . The National Pregnancy in Diabetes Audit: measuring the quality of diabetes pregnancy care. Diabet Med. 2013; 30(9):1014-6. DOI: 10.1111/dme.12277. View

Conde-Agudelo A, Bird S, Kennedy S, Villar J, Papageorghiou A . First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis. BJOG. 2014; 122(1):41-55. DOI: 10.1111/1471-0528.13096. View

Bestwick J, Huttly W, Morris J, Wald N . Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One. 2014; 9(2):e89354. PMC: 3929694. DOI: 10.1371/journal.pone.0089354. View

10.

Murphy H, Roland J, Skinner T, Simmons D, Gurnell E, Morrish N . Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010; 33(12):2514-20. PMC: 2992180. DOI: 10.2337/dc10-1113. View

11.

Flenady V, Wojcieszek A, Middleton P, Ellwood D, Erwich J, Coory M . Stillbirths: recall to action in high-income countries. Lancet. 2016; 387(10019):691-702. DOI: 10.1016/S0140-6736(15)01020-X. View

12.

Feig D, Asztalos E, Corcoy R, DE Leiva A, Donovan L, Hod M . CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol. BMC Pregnancy Childbirth. 2016; 16(1):167. PMC: 4950103. DOI: 10.1186/s12884-016-0961-5. View

13.

Smith G . Screening and prevention of stillbirth. Best Pract Res Clin Obstet Gynaecol. 2016; 38:71-82. DOI: 10.1016/j.bpobgyn.2016.08.002. View

14.

Balsells M, Garcia-Patterson A, Gich I, Corcoy R . Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009; 94(11):4284-91. DOI: 10.1210/jc.2009-1231. View

15.

Evers I, de Valk H, H A Visser G . Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004; 328(7445):915. PMC: 390158. DOI: 10.1136/bmj.38043.583160.EE. View

16.

Murphy H, Elleri D, Allen J, Harris J, Simmons D, Rayman G . Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2011; 55(2):282-93. DOI: 10.1007/s00125-011-2363-6. View

17.

Macintosh M, Fleming K, Bailey J, Doyle P, Modder J, Acolet D . Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006; 333(7560):177. PMC: 1513435. DOI: 10.1136/bmj.38856.692986.AE. View

18.

Holman N, Bell R, Murphy H, Maresh M . Women with pre-gestational diabetes have a higher risk of stillbirth at all gestations after 32 weeks. Diabet Med. 2014; 31(9):1129-32. DOI: 10.1111/dme.12502. View

19.

Temple R, Murphy H . Type 2 diabetes in pregnancy - An increasing problem. Best Pract Res Clin Endocrinol Metab. 2010; 24(4):591-603. DOI: 10.1016/j.beem.2010.05.011. View

20.

Goudie R, Lunn D, Hovorka R, Murphy H . Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care. 2014; 37(6):e121-2. DOI: 10.2337/dc13-2535. View